Use Of Lgg In The Manufacture Of A Medicament For The Prevention Or Treatment Of Respiratory Allergies

Patent No. EP1868623 (titled "Use Of Lgg In The Manufacture Of A Medicament For The Prevention Or Treatment Of Respiratory Allergies") was filed by Bristol Myers Squibb on Mar 22, 2006. The application was issued on Aug 31, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
NESTECMay 30, 2017D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1868623

BRISTOL MYERS SQUIBB
Application Number
EP06739278A
Filing Date
Mar 22, 2006
Status
Revoked
Feb 8, 2019
Publication Date
Aug 31, 2016